COVID-19 Testing in the Era of Modern Neurosurgery: Mitigating Risk in Our Vulnerable Patient Populations

xlomafota13 shared this article with you from Inoreader COVID-19 Testing in the Era of Modern Neurosurgery: Mitigating Risk in Our Vulnerable Patient Populations Via leak of cerebrospinal fluid World Neurosurg. 2021 Jun 13;152:80-83. doi: 10.1016/j.wneu.2021.06.027. Online ahead of print. ABSTRACT BACKGROUND: The respiratory illness identified as coronavirus disease 2019 (COVID-19) has resulted in a pandemic illness that has changed the face of healthcare. As the COVID-19 pandemic continues, patients have continued to require neurosurgical interventions, and the endoscopic endonasal approach for surgery has continued to be a mainstay treatment of pituitary tumors and anterior skull base lesions. METHODS: We sought to highlight the current lack of recommendations regarding testing protocols for neurosurgical patients. RESULTS: We implemented a novel testing protocol for our patient populations at increased risk and have proposed a model that can be used at other institutions to mitigate the risk of complications associated with some forms of COVID-19 testing. CONCLUSION: Patients with anterior skull base defects may be at risk with current COVID-19 testing protocols, and may benefit from alternative specimen collection strategies. PMID:34133996 | PMC:PMC8197680 | DOI:10.1016/j.wneu.2021.06.027 View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.